Advaxis and Ayala Pharmaceuticals Enter into Merger Agreement

Provided By Globe Newswire

Last update: Oct 19, 2022

Merger brings U.S. management and presence, cash to develop compelling late-stage asset

Lead candidate AL102 being evaluated in ongoing Phase 2/3 RINGSIDE study, a potential registration trial in desmoid tumors